RECORDATORIO: Nuestro equipo de la línea de atención telefónica está trabajando a distancia y centrando su tiempo en ayudar a nuestros pacientes. Agradecemos a las farmacias, a los proveedores y a su personal que utilicen nuestros Portales de Farmacia y de Proveedores. Por favor, tenga en cuenta que si se pone en contacto con nosotros sobre un pago o una subvención, es más rápido enviarnos un correo electrónico a [email protected]. Le agradecemos su paciencia y esperamos seguir sirviéndole. Les deseamos a todos seguridad y buena salud durante estos momentos difíciles. El equipo de HealthWell
Sickle Cell Disease
Status
Closed
Closed Funds
This fund is temporarily closed to new patients due to lack of sufficient funding. Please continue to visit our Disease Funds page often, as replenished funds reopen as quickly as possible. If you currently have a grant with HealthWell, your grant will remain active for the entire 12 month grant cycle or until you have exhausted your allocated grant amount, whichever comes first. You can continue to use your pharmacy card or submit requests for reimbursements during your designated grant cycle.
Fund Type
CopayPremium (Medicare Part B only)
Maximum Award Level
Pharmacy Card Fund
YesMinimum CopayReimbursement Amount
Minimum Copay Reimbursement Amount
We encourage you to please use your HealthWell pharmacy card for any applicable charges as possible.
Minimum Premium
Reimbursement Amount
Household Income Limit
500% of the Federal Poverty Level(adjusted for household size and high
cost of living areas)
Treatments Covered
- Adakveo
- Casgevy
- Deferasirox
- Desferal
- Droxia
- Endari
- Ery-tab
- Erygel
- Exjade
- Ferriprox
- Folacin-800 (no Otc)
- Hydrea
- Inomax
- Jadenu
- Lyfgenia
- Pentoxifylline
- Piracetam
- Siklos
- Vitamin B9 (no Otc)
Fund Definition
Assistance with the prescription drugs and biologics used in the treatment or management of Sickle Cell Disease.
Grant Utilization
HealthWell estimates that patients use an average of $3,780 during their 12-month grant period for this disease area.
Do I Qualify?
HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:
-
Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Diseases and Medications listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.
-
To qualify for copayment assistance from HealthWell, you must have some form of health insurance (private insurance, Medicare, Medicaid, TriCare, etc.) that covers part of the cost of your treatment. Please note that in order to qualify for premium assistance through this fund, you must have Medicare Part B. The Foundation will refer patients without prescription insurance to other programs, such as manufacturer patient assistance programs.
-
HealthWell assists individuals with incomes up to 300-500% of the Federal Poverty Level. The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.
-
If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.
About Sickle Cell Disease
Sickle cell disease (SCD) is an inherited blood disorder that affects red blood cells. People with sickle cell disease have an abnormal type of hemoglobin, the red blood cells that contain mostly hemoglobin S, according to the Sickle Cell Disease Association of America (SCDAA). These red blood cells can become sickle-shaped (crescent shaped) and have difficulty passing through small blood vessels. Sickle-shaped cells block small blood vessels resulting in less blood flow in that part of the body. Tissue that does not receive a normal blood flow eventually becomes damaged, causing complications of the disease. Sickle cells are destroyed rapidly in the body causing complications, including anemia, jaundice and formation of gallstones.
According to the Centers for Disease Control and Prevention, nearly 100,000 individuals in the U.S. have sickle cell disease. It is estimated that sickle cell disease affects 1 out of every 365 black or African-American births, and 1 out of every 16,300 Hispanic-American births. There is currently no universal cure for sickle cell disease. Sources: Sickle Cell Disease Association of America and Centers for Disease Control and Prevention
Additional Educational Resources
You may also visit our Resource List to view other copayment organizations that may provide assistance.
